Peggy Chiang

Strategies for the modulation of phase II metabolism in a series of PKCε inhibitors.

R. Heim, J. Abt, A. Termin, 2014, Bioorganic & medicinal chemistry letters.

Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating CNS disorders such as Huntington's disease.

Beth A. Fleck, L. Goulet, J. Ernst, 2014, Journal of medicinal chemistry.

Application of a high‐resolution in vitro human MDR1‐MDCK assay and in vivo studies in preclinical species to improve prediction of CNS drug penetration

P. Eddershaw, Weichao G. Chen, Peggy Chiang, 2022, Pharmacology research & perspectives.

Antimalarial Activities of Novel Synthetic Cysteine Protease Inhibitors

Philip J. Rosenthal, Ajay Singh, Scott J. Kemp, 2003, Antimicrobial Agents and Chemotherapy.